Further studies led to the discovery that, unlike Ras inhibition in Src-transformed fibroblasts[19], Stat3 inhibition in NSCLC lines with high Src activity does not restore GJIC. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.